Amelie Marguier
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy.
Journal: Methods in cell biology
Published: October 11, 2024
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.
Journal: Breast cancer research : BCR
Published: August 26, 2024
TIE-2-Expressing Monocytic Myeloid-Derived Suppressor Cells Are Involved in Resistance to Anti-PD-1 Therapy Mediated by Angiopoietin 2 in Patients with Melanoma.
Journal: The Journal of investigative dermatology
Published: September 19, 2023
Chemotherapy to potentiate the radiation-induced immune response.
Journal: International review of cell and molecular biology
Published: March 30, 2023
Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4 + Th1 Response in Metastatic Non-Small Cell Lung Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 30, 2022
TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition.
Journal: Frontiers in immunology
Published: April 29, 2022
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: January 10, 2022
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.
Journal: Journal for immunotherapy of cancer
Published: June 08, 2021
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Journal: The Journal of investigative dermatology
Published: November 18, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026